What the Mount Raymond acquisition means for SLAM Exploration Ltd.’s Goodwin project scale (TSXV: SXL)
Read More 7 minute read Pharma Industry News GSK’s B7-H3 ADC secures EU orphan drug status as it accelerates global lung cancer trials GSK’s B7-H3-targeted ADC GSK’227 receives EU Orphan Drug Designation for small-cell lung cancer. Learn how it fits into the company’s expanding global trial program. byVenkateshOctober 30, 2025